Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anticoagulation With Apixaban”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT02179177
What this trial is testing

Apixaban in Patients With Sickle Cell Disease

Who this might be right for
Vaso-occlusive CrisisReduction in HospitalizationsSickle Cell Disease
Nirmish Shah 16
Post-approval studies (Phase 4)Ended earlyNCT03678506
What this trial is testing

Apixaban for Extended Anticoagulation (APIDULCIS)

Who this might be right for
Venous ThromboembolismAnticoagulants
Arianna Anticoagulazione Foundation 800
Not applicableLooking for participantsNCT07559942
What this trial is testing

Effect of Apiban Therapy on AVF Maturation in ESRD Patients

Who this might be right for
Endstage Renal DiseaseDirect Oral Anticoagulants (DOACs)Arteriovenous Fistula+1 more
Combined military hospital lahore 190
Not applicableUnknownNCT02635230
What this trial is testing

What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.

Who this might be right for
Atrial FibrillationsHeart Valve ProsthesesAcute Coronary Syndromes+4 more
R&D Cardiologie 2,200
Testing effectiveness (Phase 2)Study completedNCT02565693
What this trial is testing

Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation

Who this might be right for
Cerebral HemorrhageAtrial Fibrillation
UMC Utrecht 101
Not applicableStudy completedNCT02674594
What this trial is testing

Evaluation of Hospital Readmissions Among Hospitalized Non-valvular Atrial Fibrillation (NVAF) Patients in the US

Who this might be right for
Nonvalvular Atrial Fibrillation
Bristol-Myers Squibb 30,000
Testing effectiveness (Phase 2)Looking for participantsNCT05869591
What this trial is testing

DOAC in Patients with Child a or B Liver Cirrhosis

Who this might be right for
Liver Cirrhosis
Centre Hospitalier Universitaire Vaudois 40
Large-scale testing (Phase 3)Looking for participantsNCT05679024
What this trial is testing

Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation

Who this might be right for
Chronic Kidney DiseasesAtrial FibrillationStroke+6 more
Region Stockholm 1,400
Testing effectiveness (Phase 2)Study completedNCT02981472
What this trial is testing

The Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation

Who this might be right for
Thrombosis
Bristol-Myers Squibb 192
Not applicableNot Yet RecruitingNCT06869083
What this trial is testing

Application-Delivered Patient Education in Enhancing the Usage of Apixaban in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation on Apixaban Treatment
Yonsei University 5,200
Not applicableStudy completedNCT02591732
What this trial is testing

A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark

Who this might be right for
Anticoagulation
Bristol-Myers Squibb 52,178
Large-scale testing (Phase 3)Study completedNCT00423319
What this trial is testing

Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Bristol-Myers Squibb 5,407
Not applicableStudy completedNCT03073265
What this trial is testing

Apixaban Validation Study - Additional Study on Fresh Samples

Who this might be right for
Anticoagulation With Apixaban
Diagnostica Stago 109
Large-scale testing (Phase 3)Study completedNCT02369653
What this trial is testing

The Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase

Who this might be right for
LymphomaAcute Lymphoblastic Leukemia
Bristol-Myers Squibb 512
Not applicableEnrolling By InvitationNCT07242326
What this trial is testing

SNAP AF-52: Dose Appropriateness and Adherence to Oral Anticoagulation in Adults ≥65 With Atrial Fibrillation in Primary Care (Ordu, Türkiye)

Who this might be right for
Medication AdherenceAtrial Fibrillation (AF)Direct Oral Anticoagulants (DOACs)
Kotyora Family Medicine Health Management and Education Association 1,000
Large-scale testing (Phase 3)Study completedNCT02933697
What this trial is testing

Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD)

Who this might be right for
Atrial FibrillationEnd-stage Kidney Disease
Atrial Fibrillation Network 108
Not applicableStudy completedNCT03148457
What this trial is testing

Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial

Who this might be right for
Ischaemic Stroke
Insel Gruppe AG, University Hospital Bern 2,013
Post-approval studies (Phase 4)Study completedNCT04168203
What this trial is testing

Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism

Who this might be right for
Deep Vein ThrombosisPulmonary EmbolismVenous Thromboembolism
Brigham and Women's Hospital 600
Post-approval studies (Phase 4)Study completedNCT01706146
What this trial is testing

Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring

Who this might be right for
Atrial Fibrillation
Northwestern University 59
Testing effectiveness (Phase 2)Study completedNCT03251482
What this trial is testing

Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery

Who this might be right for
VTE Prophylaxis With Anticoagulation After Total Knee Replacement Surgery
Janssen Research & Development, LLC 308
Next Page